BRIGHT PEAK
Live / Registered — Registered (as of 11 Jan 2022)
What this means for you
Registered since 11 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79285070
- Registration number
- 6610085
- Mark type
- Stylized text
- Filed
- 25 Mar 2020
- Published for opposition
- 26 Oct 2021
- Registered
- 11 Jan 2022
- Attorney of record
- MONICA RIVA TALLEY
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; medical and veterinary preparations, namely, recombinant or chemically synthesized and optimized proteins; preparations for destroying vermin; fungicides, herbicides; biotechnological preparations, namely, recombinant or chemically synthesized and optimized proteins for medical use; enzymes for medical use; enzymes for veterinary use; biological and chemical reagents for medical or veterinary use; amino acids for medical use; amino acids for veterinary use; peptides for medical or veterinary use, namely, for the treatment of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; proteins for medical or veterinary use, namely, recombinant or chemically synthesized and optimized proteins for detection and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, nutritional diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; pharmaceutical preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical compositions and preparations for cancer prevention and treatment; pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; pharmaceutical preparations for treatment of skin diseases; pharmaceutical preparations for treatment of neurodegenerative, metabolic and ophthalmological diseases
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, scientific analysis, and scientific testing in the field of biotechnology and new product research and design services relating thereto; research and development in the field of biotechnology; consulting services in the field of biotechnology; scientific research services in the field of proteins, peptides and antibodies, and scientific advice relating thereto; scientific research services for medical purposes in the field of cancer and autoimmune diseases and scientific advice relating thereto
Owner
Prosecution history
- 18 Jul 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 23 Jun 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Jun 2022 — FINAL DISPOSITION PROCESSED
- 11 Apr 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Nov 2021 — NOTIFICATION PROCESSED BY IB
- 03 Nov 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 26 Oct 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Oct 2021 — PUBLISHED FOR OPPOSITION
- 13 Oct 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 13 Oct 2021 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 06 Oct 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 06 Oct 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 06 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Sept 2021 — LAW OFFICE PUBLICATION REVIEW COMPLETED